Phase II Study of Oral Rigosertib #ASH19 @MountSinaiNYC

Phase II Study of Oral Rigosertib #ASH19 @MountSinaiNYC

ash

6 months
388 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

Shyamala Navada, MD of @MountSinaiNYC discusses the phase II study of oral rigosertib combined with azacitidine as first line therapy in patients with HR-MDS.

Up Next Autoplay